Nimartem

Nimartem

Nimartem is an Artemisinin Combination Therapy (ACT) that has Artemether and Lumefantrine as its active constituents.

  • Description

Description

Nimartem is an Artemisinin Combination Therapy (ACT) that has Artemether and Lumefantrine as its active constituents.

Indication:

  • Treatment of uncomplicated Falciparum malaria.

Artemether is believed to interact with the haem iron of the parasite via its endoperoxide bridge to generate reactive free-radicals or metabolites, which are cytotoxic to the parasite.

Lumefantrine (A highly lipophilic aryl amino alcohol structurally resembling halofantrine) -Is thought to interfere with polymerization, a critical detoxifying pathway for the parasite.

FEATURES BENEFITS
Locally manufactured. It is readily available.
High clearance rate of malaria parasite. Reduces the chance   of relapse.
Dosage regimen on the pack. Ensures compliance and best clinical results.
Cost-effective Affordable for patients.
Rapidly effective High cure rate.

 

Dosage:

Nimartem Qs:

1 tablet twice daily for 3 days

Nimartem*24:

Children: Dose depends on body weight.

Adult: 4 tablets twice daily for 3 days.

 

….Neimeth Malaria Terminator